Asuragen, Inc.
Newly launched Asuragen closes series A funding of $49 million
Published in Healthcare Finance, Tax and Law Weekly, June 28th, 2006
Asuragen, a spin-off of Ambion Inc., will dedicate the funds towards general operating needs and to pursue strategic licenses relating to the development of its cancer diagnostic and therapeutic programs.
This initial round of investment, led by San Francisco, California, based Telegraph Hill Partners, included Houston based Growth Capital Partners and other firms that invested in Ambion, Inc.
Rollie Carlson joins Asuragen as president from Abbott Laboratories, has extensive experience in molecular diagnostic and pharmaceutical business areas. Most...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Healthcare Finance, Tax and Law Weekly
More Articles from Healthcare Finance, Tax and Law Weekly
- Acura Pharmaceuticals, Inc.
Acura Pharmaceuticals secures bridge funding - American Association for the Study of Liver Diseases
Education and guidelines needed for genetic testing in liver disease - Antares Pharma, Inc.
Antares Pharma, Eli Lilly file joint patent application for needle-free injection device - Ascentia Biomedical Corp.
Ascentia Biomedical shifts to biomedical arbitrage, development to achieve profitability - AstraZeneca
AstraZeneca invests $100M in China research and development - Avid Radiopharmaceuticals, Inc.
Avid Radiopharmaceuticals adds three industry veterans - More from this issue of Healthcare Finance, Tax and Law Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
